CORRECTION - BrainsWay Reports First Quarter 2020 Financial Results and Operational HighlightsGlobeNewsWire • 06/24/20
BrainsWay Reports First Quarter 2020 Financial Results and Operational HighlightsGlobeNewsWire • 06/24/20
BrainsWay Strengthens Senior Leadership Team with Appointment of Christopher Boyer as Vice President of Global MarketingGlobeNewsWire • 05/20/20
BrainsWay Enhances Senior Leadership with Promotion and New Executive AdditionGlobeNewsWire • 05/06/20
BrainsWay Launches #StandAgainstTheStigma Campaign to Promote Mental Health Awareness MonthGlobeNewsWire • 05/04/20
Brainsway Ltd. (BWAY) CEO Christopher von Jako on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/23/20
BrainsWay Announces Data from Feasibility Study of Deep Transcranial Magnetic Stimulation System in the treatment of Adults with ADHDGlobeNewsWire • 02/10/20
BrainsWay Reports Results of Interim Analysis of H7 Deep Transcranial Magnetic Stimulation Study in Post-Traumatic Stress DisorderGlobeNewsWire • 02/06/20
BrainsWay Announces Successful Results in Pivotal Multicenter Study Evaluating Deep Transcranial Magnetic Stimulation System as an Aid in Smoking CessationGlobeNewsWire • 12/02/19
Brainsway Ltd. (BWAY) CEO David Zacut on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/25/19
BrainsWay Appoints Medical Technology Industry Leader Christopher R. von Jako, Ph.D.GlobeNewsWire • 11/25/19
BrainsWay‘s New Stimulator for Deep Transcranial Magnetic Stimulation Makes German Debut at the 2019 German Association for Psychiatry, Psychotherapy and Psychosomatics CongressGlobeNewsWire • 11/25/19
A Stepping Stone Hosts Open House to Introduce Newly Offered FDA-Cleared Helmet to Treat Major Depressive Disorder (MDD)GlobeNewsWire • 10/29/19